Ami Fadia
Stock Analyst at Needham
(3.31)
# 1,000
Out of 4,941 analysts
380
Total ratings
42.61%
Success rate
3.55%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $57 → $56 | $35.26 | +58.82% | 25 | Aug 7, 2025 | |
| MRUS Merus | Maintains: Buy | $97 → $96 | $63.76 | +50.56% | 30 | Aug 6, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $18 → $16 | $6.14 | +160.59% | 21 | Aug 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $150 | $105.23 | +42.54% | 16 | Aug 4, 2025 | |
| ALKS Alkermes | Reiterates: Buy | $45 | $27.43 | +64.05% | 3 | Jul 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $25.45 | +17.88% | 10 | Jun 26, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $9 | $3.25 | +176.92% | 17 | Jun 18, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $11.56 | - | 23 | Jun 17, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $48.46 | +65.08% | 12 | Jun 12, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $128.93 | - | 41 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $113.33 | +78.24% | 32 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $17.15 | +104.08% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.50 | +233.33% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $13.40 | +41.79% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $35.47 | +38.14% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $128.89 | +7.84% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.22 | +301.66% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $14.88 | +2,050.54% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $24.81 | +202.30% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.77 | +2,810.74% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $23.07 | +173.08% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $4.80 | +4.17% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $16.60 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.31 | +1,579.39% | 4 | Jan 3, 2018 |
Revolution Medicines
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $56
Current: $35.26
Upside: +58.82%
Merus
Aug 6, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $63.76
Upside: +50.56%
Day One Biopharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $6.14
Upside: +160.59%
Axsome Therapeutics
Aug 4, 2025
Reiterates: Buy
Price Target: $150
Current: $105.23
Upside: +42.54%
Alkermes
Jul 29, 2025
Reiterates: Buy
Price Target: $45
Current: $27.43
Upside: +64.05%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $25.45
Upside: +17.88%
Immuneering
Jun 18, 2025
Reiterates: Buy
Price Target: $9
Current: $3.25
Upside: +176.92%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.56
Upside: -
Praxis Precision Medicines
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $48.46
Upside: +65.08%
Biogen
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $128.93
Upside: -
Jun 11, 2025
Reiterates: Buy
Price Target: $202
Current: $113.33
Upside: +78.24%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $17.15
Upside: +104.08%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.50
Upside: +233.33%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $13.40
Upside: +41.79%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $35.47
Upside: +38.14%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $128.89
Upside: +7.84%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.22
Upside: +301.66%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $14.88
Upside: +2,050.54%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $24.81
Upside: +202.30%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.77
Upside: +2,810.74%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $23.07
Upside: +173.08%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $4.80
Upside: +4.17%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $16.60
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.31
Upside: +1,579.39%